Asep Medical Holdings Inc. Sample Contracts

COLLABORATIVE RESEARCH AGREEMENT
Collaborative Research Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at 103 – 6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3 (“UBC”)

Sample 1Sample 2Sample 3See All (7)
AutoNDA by SimpleDocs
Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as...
Amalgamation Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
Sample 1Sample 2Sample 3
ESCROW AGREEMENT
Escrow Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances

THIS AGREEMENT is being entered into by the Parties under National Policy 46-201 Escrow for Initial Public Offerings (the “Policy”) in connection with the proposed non-offering prospectus by the Issuer, an emerging issuer.

Sample 1Sample 2Sample 3
EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

ASEP MEDICAL HOLDINGS INC., a British Columbia company, having its principal office located at 420 – 730 View Street, Victoria, British Columbia, V8W 3Y7

Sample 1Sample 2
Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as...
Feasibility Study Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

ABT INNOVATIONS INC., a company incorporated under the British Columbia Corporations Act and having its administrative offices at 200-931 Fort Street, Victoria, B.C. VBV 3K3 (“ABT”), Attention: Dr. Robert E. W. Hancock (“Provider Scientist”), Telephone: __________, E-mail: __________

Sample 1Sample 2
LICENSE AGREEMENT Between: THE UNIVERSITY OF BRITISH COLUMBIA and ABT INNOVATIONS INC. Schedules
License Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at #103-6190 Agronomy Road, Vancouver, British Columbia, V6T 123

Sample 1Sample 2
OPTION AGREEMENT
Option Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

THIS AGREEMENT is dated as of May 14 , 2021 (the “Effective Date”) among ASEP Medical Inc. (the “Optionee”), Sepset Biosciences Inc. (the “Optionor”) and each of the securityholders of the Optionor listed in Schedule “A” hereto (collectively, the “Securityholders” and individually each a “Securityholder”) including without limitation CDRD Ventures Inc. (the “Creditor”). The Optionor, the Optionee and each Securityholder are referred to herein as a “Party”, and together as the “Parties”.

Sample 1Sample 2
SHARE PURCHASE OPTION AGREEMENT
Share Purchase Option Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

THIS AGREEMENT made as of the 14th day of May, 2021 (the “Effective Date”) between THE UNIVERSITY OF BRITISH COLUMBIA (“UBC”), ABT INNOVATIONS INC. (the “Company”) and ASEP MEDICAL INC. (the “Optionee”).

Sample 1Sample 2
START-UP LICENSE AGREEMENT Between: THE UNIVERSITY OF BRITISH COLUMBIA and SAFECOAT MEDICAL INC
Start-Up License Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at #103-6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3

Sample 1Sample 2
OPTION AGREEMENT
Option Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

THIS AGREEMENT is dated as of May 14, 2021 (the “Effective Date”) among ASEP Medical Inc. (the “Optionee”), ABT Innovations Inc. (the “Optionor”) and each of the securityholders of the Optionor listed in Schedule “A” hereto (except UBC) (collectively, the “Securityholders” and individually each a “Securityholder”). The Optionor, the Optionee and each Securityholder are referred to herein as a “Party”, and together as the “Parties”.

Sample 1Sample 2
Contract
Employment Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as private or confidential.

Sample 1Sample 2
EARN-IN AND OPTION AGREEMENT
Earn-in and Option Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

FOR VALUABLE CONSIDERATION, the receipt and sufficiency of which is hereby acknowledged by the undersigned, the undersigned hereby:

Sample 1Sample 2
LICENSE AGREEMENT
License Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

SEPSET BIOSCIENCES INC., a corporation incorporated under the laws of British Columbia, with a registered and records office at Suite 700 - 401 West Georgia Street, Vancouver, BC Canada V68 5A1

Sample 1Sample 2
Contract
Consulting Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances

Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as private or confidential.

Sample 1Sample 2
Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as...
Collaborative Research Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances

Re: Collaborative Research Agreement between The University of British Columbia (“UBC”) and ABT Innovations Inc. (the “Sponsor”) effective as of June 2, 2021 (the “Agreement”); Amendment No. 1

Sample 1Sample 2
FIRST AMENDMENT TO CONFIDENTIAL DISCLOSURE AGREEMENT DATED 22 SEPTEMBER 2016
Confidential Disclosure Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances

This First Amendment (the “Amendment”) to the Confidential Disclosure Agreement, dated 22 September 2016 (the “Agreement”), between ABT Innovations (“COMPANY”) and iFyber LLC (“IFYBER”), is entered into as of 18 May 2021.

Sample 1Sample 2
EMPLOYMENT AGREEMENT THIS AGREEMENT is made on the 1st day of June 2021. BETWEEN
Employment Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

WHEREAS the Employer desires to obtain the benefit of the services of the Employee, and the employee desires to render such services on the terms and conditions set forth;

Sample 1Sample 2
CONSULTING AGREEMENT
Consulting Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

WHEREAS the Company desires to obtain the benefit of the services of the Consultant, and the Consultant desires to render such services on the terms and conditions set forth;

Sample 1Sample 2
JOINT VENTURE AND LICENSE AGREEMENT
Joint Venture and License Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

NOW THEREFORE, in consideration of the mutual covenants in this Agreement and other good and valuable consideration, the receipt and sufficiency of all of which are hereby acknowledged by each Party, the Parties covenant and agree as follows:

Sample 1Sample 2
Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as...
Consulting Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

WHEREAS the Company desires to obtain the benefit of the services of the Consultant, and the Consultant desires to render such services on the terms and conditions set forth;

Sample 1Sample 2
EMPLOYEE EMPLOYMENT AGREEMENT
Employee Employment Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia

ASEP MEDICAL HOLDINGS INC., a British Columbia company, having its principal office located at 420 – 730 View Street, Victoria, British Columbia, V8W 3Y7

Sample 1Sample 2
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!